PAA 8.89% 20.5¢ pharmaust limited

Global 70 kDa Ribosomal Protein S6 Kinase Market 2019 – ArQule,...

  1. 11,717 Posts.
    lightbulb Created with Sketch. 5939

    Global 70 kDa Ribosomal Protein S6 Kinase Market 2019 – ArQule, Inc., Astex Pharmaceuticals Inc, Eddingpharm, Merck KGaA, PharmAust Limited


    Report contains wide array of statistical surveying of 70 kDa Ribosomal Protein S6 Kinase Market which enable clients to break down the future scenario and foresee correct implementation. The data is based on the precise investigation of authentic data of 70 kDa Ribosomal Protein S6 Kinase market. It has included constraints and drivers after the complete analysis of this market. It is made by taking into consideration about its basic data across the world.

    Our expertise has assessed the market with pin-point analysis of key players worldwide,
    ArQule, Inc.
    Astex Pharmaceuticals Inc
    Eddingpharm
    Merck KGaA
    PharmAust Limited
    Phoenix Biotechnology, Inc.
    Sentinel Oncology Limited

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
-0.020(8.89%)
Mkt cap ! $81.16M
Open High Low Value Volume
20.0¢ 21.0¢ 19.5¢ $331.9K 1.617M

Buyers (Bids)

No. Vol. Price($)
4 440882 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 12736 3
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.